Skip to main content
Figure 2 | Journal of Neuroinflammation

Figure 2

From: Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population

Figure 2

Schematic setup of in vitro MAPC, splenocyte, and microglia/macrophage interactions. (A) Isolated splenocytes are activated with 2 μg/ml of ConA. Two hours after isolation, MAPC were added at a ratio of 1:5 (MAPC:splenocyte) in co-culture or transwell cultures. 24 hours after the first dose of MAPCs, a second dose of MAPCs were added at the same ratio. 48 hours after the splenocyte harvest, supernatants were collected from each specific condition. (B) The supernatant was then used to stimulate LPS-activated microglia. (C) Microglia/macrophages were characterized via flow cytometry, immunostained or measured for proliferation using the MTS proliferation assay. LPS, lipopolysaccharide; MAPCs, multipotent adult progenitor cells; MTS.

Back to article page